What's in a disease name?

British Journal of Dermatology

Volumn 170, Issue 5, 2014, Pages 1005-1007

  Sprecher, E ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKERATIN 14; DESMOGLEIN 1;

ANAMNESIS; CLINICAL FEATURE; EDITORIAL; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; ICHTHYOSIS; INHERITANCE; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DISEASE; DERMATOLOGY; NOMENCLATURE; SKIN DISEASES;

DERMATOLOGY; GENETIC TESTING; HUMANS; PHYSICAL EXAMINATION; SKIN DISEASES; TERMINOLOGY AS TOPIC;

EID: 84901020040     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13019     Document Type: Editorial

References (33)

1. Lane EB, McLean WH,. Keratins and skin disorders. J Pathol 2004; 204: 355-66.
2. McLean WH, Moore CB,. Keratin disorders: from gene to therapy. Hum Mol Genet 2011; 20: R189-97.
3. Abu Sa'dJ, Indelman M, Pfendner E, et al,. Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population. J Invest Dermatol 2006; 126: 777-81.
4. Nousbeck J, Padalon-Brauch G, Fuchs-Telem D, et al,. Semidominant inheritance in epidermolytic ichthyosis. J Invest Dermatol 2013; 133: 2626-8.
5. Padalon-Brauch G, Ben Amitai D, Vodo D, et al,. Digenic inheritance in epidermolysis bullosa simplex. J Invest Dermatol 2012; 132: 2852-4.
6. Li Q, Grange DK, Armstrong NL, et al,. Mutations in the GGCX and ABCC6 genes in a family with pseudoxanthoma elasticum-like phenotypes. J Invest Dermatol 2009; 129: 553-63.
7. van Tuyll van Serooskerken AM, de Rooij FW, Edixhoven A, et al,. Digenic inheritance of mutations in the coproporphyrinogen oxidase and protoporphyrinogen oxidase genes in a unique type of porphyria. J Invest Dermatol 2011; 131: 2249-54.
8. Gropman AL, Adams DR,. Atypical patterns of inheritance. Semin Pediatr Neurol 2007; 14: 34-45.
9. Braun-Falco M, Kovnerystyy O, Lohse P, et al,. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012; 66: 409-15.
10. Geusau A, Mothes-Luksch N, Nahavandi H, et al,. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatol 2013; 149: 209-15.
11. Marzano AV, Trevisan V, Gattorno M, et al,. Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene. JAMA Dermatol 2013; 149: 762-4.
12. Wise CA, Gillum JD, Seidman CE, et al,. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 2002; 11: 961-9.
13. Uttam J, Hutton E, Coulombe PA, et al,. The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci USA 1996; 93: 9079-84.
14. Harel A, Bergman R, Indelman M, et al,. Epidermolysis bullosa simplex with mottled pigmentation resulting from a recurrent mutation in KRT14. J Invest Dermatol 2006; 126: 1654-7.
15. Hamada T, Yasumoto S, Karashima T, et al,. Recurrent p.N767S mutation in the ATP2A2 gene in a Japanese family with haemorrhagic Darier disease clinically mimicking epidermolysis bullosa simplex with mottled pigmentation. Br J Dermatol 2007; 157: 605-8.
16. Fuchs-Telem D, Sarig O, van Steensel MA, et al,. Familial pityriasis rubra pilaris is caused by mutations in CARD14. Am J Hum Genet 2012; 91: 163-70.
17. Jordan CT, Cao L, Roberson ED, et al,. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. Am J Hum Genet 2012; 90: 796-808.
18. Jordan CT, Cao L, Roberson ED, et al,. PSORS2 is due to mutations in CARD14. Am J Hum Genet 2012; 90: 784-95.
19. Eytan O, Qiaoli L, Nousbeck J, et al,. Increased epidermal expression and absence of mutations in CARD14 in a series of sporadic PRP patients. Br J Dermatol 2013 [Epub ahead of print].
20. Petrof G, Mellerio JE, McGrath JA,. Desmosomal genodermatoses. Br J Dermatol 2012; 166: 36-45.
21. Samuelov L, Sarig O, Harmon RM, et al,. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 2013; 45: 1244-8.
22. Eytan O, Morice-Picard F, Sarig O, et al,. Cole disease results from mutations in ENPP1. Am J Hum Genet 2013; 93: 752-7.
23. Li Q, Schumacher W, Jablonski D, et al,. Cutaneous features of pseudoxanthoma elasticum in a patient with generalized arterial calcification of infancy due to a homozygous missense mutation in the ENPP1 gene. Br J Dermatol 2012; 166: 1107-11.
24. Lorenz-Depiereux B, Schnabel D, Tiosano D, et al,. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 2010; 86: 267-72.
25. Sprecher E, Ishida-Yamamoto A, Becker OM, et al,. Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 2001; 116: 511-19.
26. Betz RC, Planko L, Eigelshoven S, et al,. Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am J Hum Genet 2006; 78: 510-19.
27. Topaz O, Shurman DL, Bergman R, et al,. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 2004; 36: 579-81.
28. Frishberg Y, Topaz O, Bergman R, et al,. Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders. J Mol Med (Berl) 2005; 83: 33-8.
29. Liao H, Waters AJ, Goudie DR, et al,. Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 2007; 127: 2795-8.
30. Titeux M, Pendaries V, Tonasso L, et al,. A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum Mutat 2008; 29: 267-76.
31. Rauen KA,. The RASopathies. Annu Rev Genomics Hum Genet 2013; 14: 355-69.
32. Tidyman WE, Rauen KA,. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 2009; 19: 230-6.
33. Rinne T, Brunner HG, van Bokhoven H,. p63-associated disorders. Cell Cycle 2007; 6: 262-8.